Citigroup
MGNX icon

Citigroup’s MacroGenics MGNX Stock Holding History

Citigroup’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.9K Buy
+33,513
New +$71.5K ﹤0.01% 4298
2025
Q4 		– Sell
-1,779
Closed -$2.99K – 6298
2025
Q3 		$2.99K Sell
1,779
-33,411
-95% -$54.1K ﹤0.01% 5383
2025
Q2 		$42.6K Sell
35,190
-10,667
-23% -$15.5K ﹤0.01% 4850
2025
Q1 		$58.2K Sell
45,857
-4,292
-9% -$11.2K ﹤0.01% 4837
2024
Q4 		$163K Buy
50,149
+4,506
+10% +$16.2K ﹤0.01% 4539
2024
Q3 		$150K Buy
45,643
+21,008
+85% +$81.8K ﹤0.01% 4549
2024
Q2 		$105K Sell
24,635
-280,441
-92% -$2.73M ﹤0.01% 4187
2024
Q1 		$4.49M Buy
305,076
+258,605
+556% +$3.91M ﹤0.01% 1787
2023
Q4 		$447K Buy
46,471
+44,286
+2,027% +$306K ﹤0.01% 3483
2023
Q3 		$10.2K Sell
2,185
-18,323
-89% -$91.2K ﹤0.01% 4537
2023
Q2 		$110K Buy
20,508
+18,563
+954% +$115K ﹤0.01% 4203
2023
Q1 		$13.9K Sell
1,945
-508
-21% -$3.06K ﹤0.01% 4624
2022
Q4 		$16.5K Sell
2,453
-1,438
-37% -$7.89K ﹤0.01% 4664
2022
Q3 		$13K Sell
3,891
-2,411
-38% -$9.22K ﹤0.01% 4902
2022
Q2 		$19K Sell
6,302
-29,784
-83% -$157K ﹤0.01% 5035
2022
Q1 		$318K Sell
36,086
-108,664
-75% -$1.2M ﹤0.01% 3807
2021
Q4 		$2.32M Buy
144,750
+3,628
+3% +$68.3K ﹤0.01% 2496
2021
Q3 		$2.96M Sell
141,122
-49,457
-26% -$1.19M ﹤0.01% 2214
2021
Q2 		$5.12M Buy
190,579
+51,408
+37% +$1.51M ﹤0.01% 1873
2021
Q1 		$4.43M Buy
139,171
+123,240
+774% +$2.99M ﹤0.01% 1867
2020
Q4 		$364K Buy
15,931
+6,679
+72% +$154K ﹤0.01% 4493
2020
Q3 		$233K Sell
9,252
-21,687
-70% -$592K ﹤0.01% 4508
2020
Q2 		$864K Sell
30,939
-7,863
-20% -$137K ﹤0.01% 3711
2020
Q1 		$226K Buy
38,802
+2,568
+7% +$23.3K ﹤0.01% 4623
2019
Q4 		$394K Sell
36,234
-13,432
-27% -$133K ﹤0.01% 4633
2019
Q3 		$634K Sell
49,666
-54,029
-52% -$778K ﹤0.01% 4115
2019
Q2 		$1.76M Buy
103,695
+87,479
+539% +$1.5M ﹤0.01% 3013
2019
Q1 		$292K Sell
16,216
-36,268
-69% -$627K ﹤0.01% 4729
2018
Q4 		$667K Buy
52,484
+12,844
+32% +$215K ﹤0.01% 3819
2018
Q3 		$850K Buy
39,640
+29,127
+277% +$621K ﹤0.01% 3676
2018
Q2 		$217K Sell
10,513
-3,051
-22% -$68.7K ﹤0.01% 4985
2018
Q1 		$341K Buy
13,564
+5,162
+61% +$125K ﹤0.01% 4391
2017
Q4 		$160K Sell
8,402
-8,627
-51% -$161K ﹤0.01% 5249
2017
Q3 		$315K Sell
17,029
-1,946
-10% -$33.7K ﹤0.01% 4580
2017
Q2 		$332K Buy
18,975
+1,466
+8% +$28K ﹤0.01% 4365
2017
Q1 		$325K Sell
17,509
-52,989
-75% -$1.02M ﹤0.01% 4229
2016
Q4 		$1.44M Buy
70,498
+60,312
+592% +$1.52M ﹤0.01% 3302
2016
Q3 		$305K Buy
10,186
+4,252
+72% +$126K ﹤0.01% 4335
2016
Q2 		$160K Sell
5,934
-16,764
-74% -$378K ﹤0.01% 4699
2016
Q1 		$425K Buy
22,698
+14,994
+195% +$285K ﹤0.01% 4299
2015
Q4 		$239K Sell
7,704
-15,242
-66% -$463K ﹤0.01% 4573
2015
Q3 		$491K Buy
22,946
+17,576
+327% +$551K ﹤0.01% 3764
2015
Q2 		$204K Buy
5,370
+281
+6% +$9.23K ﹤0.01% 4426
2015
Q1 		$160K Sell
5,089
-4,153
-45% -$141K ﹤0.01% 4709
2014
Q4 		$324K Buy
9,242
+7,798
+540% +$194K ﹤0.01% 4277
2014
Q3 		$30K Buy
1,444
+1,265
+707% +$26.2K ﹤0.01% 5643
2014
Q2 		$4K Sell
179
-789
-82% -$16.6K ﹤0.01% 6536
2014
Q1 		$27K Sell
968
-1,840
-66% -$65K ﹤0.01% 5865
2013
Q4 		$78K Buy
+2,808
New +$73.5K ﹤0.01% 5441

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Citigroup's MGNX Position: Q1 2026 in Review

Citigroup opened a new position in MacroGenics (MGNX) in Q1 2026: 33,513 shares worth $96.9K. The stake represents ﹤0.01% of the portfolio and ranks #4298 among its holdings. This is a return to the name: Citigroup previously reported a position in MGNX as recently as Q3 2025.

Citigroup first reported a position in MGNX in Q4 2013 and has held it in 49 quarters since. The position peaked at $5.12M in Q2 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Citigroup held 33,513 shares of MacroGenics worth $96.9K as of Q1 2026.
  • MacroGenics was a new Citigroup position in Q1 2026.
  • MacroGenics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4298 holding.
  • Citigroup first reported a position in MacroGenics in Q4 2013 and has held it in 49 quarters since.
  • Citigroup's MacroGenics position peaked at $5.12M in Q2 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.